No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Asparaginase / administration & dosage
-
Benzamides
-
Doxorubicin / administration & dosage
-
Drug Resistance, Neoplasm*
-
Fusion Proteins, bcr-abl / antagonists & inhibitors
-
Humans
-
Imatinib Mesylate
-
Male
-
Neoplasm Proteins / antagonists & inhibitors
-
Neoplasm Recurrence, Local
-
Piperazines / administration & dosage*
-
Piperazines / therapeutic use
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
-
Prednisone / administration & dosage
-
Pyrimidines / administration & dosage*
-
Pyrimidines / therapeutic use
-
Remission Induction
-
Stem Cell Transplantation
-
Transplantation, Homologous
-
Vincristine / administration & dosage
Substances
-
Benzamides
-
Neoplasm Proteins
-
Piperazines
-
Pyrimidines
-
Vincristine
-
Doxorubicin
-
Imatinib Mesylate
-
Fusion Proteins, bcr-abl
-
Asparaginase
-
Prednisone